Answers are grounded in this paper and cite their sources.
Background To assess whether vitamin D 3 supplementation attenuates the decline in daily physical activity in low‐functioning adults at risk for falls. Methods Secondary data analyses of STURDY (Study to Understand Fall Reduction and Vitamin D in You), a response‐adaptive randomized clinical trial. Participants included 571 adults aged 70 years and older with baseline serum 25(OH)D levels of 10–29 ng/mL and elevated fall risk, who wore a wrist accelerometer at baseline and at least one follow‐up visit and were randomized to receive: 200 IU/day (control), 1000, 2000, or 4000 IU/day of vitamin D 3 . Objective physical activity quantities and patterns (total daily activity counts, active minutes/day, and activity fragmentation) were measured for 7‐days, 24‐h/day, in the free‐living environment using the Actigraph GT9x over up to 24‐months of follow‐up. Results In adjusted models, physical activity quantities declined ( p < 0.001) and became more fragmented, or “broken up”, ( p = 0.017) over time. Supplementation with vitamin D 3 did not attenuate this decline. Changes in physical activity were more rapid among those with baseline serum 25(OH)D <20 ng/mL compared to those with baseline 25(OH)D levels of 20–29 ng/mL (time*baseline 25(OH)D, p < 0.05). Conclusion In low‐functioning older adults with serum 25(OH)D levels 10–29 ng/mL, vitamin D 3 supplementation of 1000 IU/day or higher did not attenuate declines in physical activity compared with 200 IU/day. Those with baseline 25(OH)D <20 ng/mL showed accelerated declines in physical activity. Alternative interventions to supplementation are needed to curb declines in physical activity in older adults with low serum 25(OH)D.
No takes yet. Share an insight, caveat, or question.
Schrack et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: